User:Maxrubin/sandbox

Arecor Limited is a biotechnology company focused on the development of formulation solutions for proteins, peptides and vaccines. Arecor was established in 2007 as a spin-out of Unilever Research and maintains Unilever Ventures as a lead investor. Arecor is based at Cambridge Science Park in the United Kingdom.

Protein Stabilisation
Therapeutic proteins are complex molecules composed of numerous reactive chemical groups and delicate three-dimensional structures. Stability can represent significant constraints in the development of new protein-based products and extending the use of existing products. Arecor has developed Arestat™, a formulation technology to stabilise proteins and protect them from damage or degradation. Arestat-T™ enhances the stability of biologics during storage at refrigerated, ambient or elevated temperatures. Arestat-C™ allows stabilisation of proteins, particularly antibodies, at high concentrations. Arestat-R™ focuses on stabilisation of biologics exposed to ionising radiation.

Partnerships
Arecor has established significant partnerships with a number of major pharmaceutical and biotechnology companies. Arecor's past and present partners include Genzyme, Compass Biotechnologies,GlaxoSmithKline and Eli Lilly.

Patents
Arecor has more than a dozen patents and patent applications, covering the company’s core enabling technologies for the stabilisation of biologics and applications in the formulation of specific products.